In a multicenter, randomized, open-label, phase 3 trial, researchers set out to determine whether an advanced surgical therapy, isolated hepatic perfusion, could improve outcomes among previously untreated...
Hypercholesterolemia and diabetes have a minimal impact on major adverse cardiovascular events (MACE) risk in patients with prostate cancer (PCa) who are treated with androgen deprivation therapy (ADT),...
The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.
A group of researchers aimed to determine the incidence rate of brain metastases in patients with metastatic uveal melanoma using data from comprehensive cancer centers.
Women with breast cancer who are receiving dose-dense paclitaxel are more likely to experience paclitaxel-induced peripheral neuropathy (PIPN) when compared with women who receive the treatment weekly,...
As neurocognitive decline occurs in the majority of patients with breast cancer, researchers conducted a blind randomized trial to determine if aerobic exercise was an effective intervention for reducing...
Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
Researchers performed a retrospective, single-center, observational cohort study to evaluate the safety outcomes of standard vs rapid infusion rates in patients who received oxaliplatin.
